|
|
Document ActionsStrong medicine
by
—
last modified
Dec 01, 2008
If EU policymakers want to stimulate innovative new drugs, they must promote public investment in medical research, improving the climate for clinical trials
Source available
here
|
|
Forgotten your Password?
Register?
